Kraig Biocraft Laboratories, Inc. (KBLB)

KBLB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	142	93	96	40	32	78
Market Cap Growth	50.22%	-3.77%	140.82%	25.13%	-58.95%	-27.40%
Enterprise Value	147	98	102	44	35	84
Last Close Price	0.13	0.09	0.09	0.04	0.03	0.08
PB Ratio	-17.75	-11.59	-11.82	-7.01	-9.07	-14.70
Debt / Equity Ratio	-0.21	-0.21	-0.21	-0.31	-0.50	-0.46
Net Debt / Equity Ratio	0.02	0.02	-0.13	0.14	0.62	-0.01
Net Debt / EBITDA Ratio	0.04	0.04	-0.34	0.31	1.05	-0.02
Net Debt / FCF Ratio	0.07	0.07	-0.56	0.64	1.16	-0.03
Quick Ratio	0.17	0.17	0.07	0.29	0.49	0.29
Current Ratio	0.18	0.18	0.08	0.29	0.49	0.29
Return on Assets (ROA)	-103.63%	-103.63%	-81.11%	-41.88%	-34.92%	-80.23%
Return on Capital Employed (ROCE)	42.80%	42.80%	37.90%	46.30%	60.60%	53.70%
Earnings Yield	-2.55%	-3.91%	-3.53%	-7.58%	-12.02%	-10.33%
FCF Yield	-1.26%	-1.94%	-1.91%	-3.13%	-5.92%	-2.44%
Buyback Yield / Dilution	-2.03%	-2.03%	-0.51%	-6.04%	-11.02%	-3.41%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.